Toggle navigation
Home
Search
Services
Blog
Contact
About
Produce Erwina L-Asparaginase for Clinical Use
Anderson, David M.
Genex Corporation, Gaithersburg, MD, United States
Search 512 grants from David Anderson
Search grants from Genex Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
TLR4 signaling in the pathogenesis of surgical necrotizing enterocolitis
PS06-618: HIV Prevention Program Targeting Young Transgender Persons of Color
DEVELOPMENT PROJECT - PET imaging of tumor vasculature
Regulation of Expression of ALDH2
Improving Adherence to Interventions for Hypertension
Recently added grants:
Dietary control of stem cells in physiology and cancer
Role of the microbiota in DNA methylation and CRC development
Averting recurrent and resistant ovarian tumors
Localized delivery of glycosaminoclycan ethers for the treatment of radiation-induced proctitis
Development of BRAF Dimer Inhibitors to Treat Drug Resistant Melanoma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067960-000
Application #
3614607
Study Section
Project Start
1986-09-22
Project End
Budget Start
1986-09-22
Budget End
1987-03-23
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Genex Corporation
Department
Type
DUNS #
City
Gaithersburg
State
MD
Country
United States
Zip Code
20877
Related projects
NIH 1987
N43 CM
Produce Erwina L-Asparaginase for Clinical Use
Filpula, David R. / Genex Corporation
NIH 1986
N43 CM
Produce Erwina L-Asparaginase for Clinical Use
Anderson, David M. / Genex Corporation
Comments
Be the first to comment on David Anderson's grant